Exchange: NASDAQ·Updated 07:54 PM EDT
KPRX logo

KPRX Kiora Pharmaceuticals Inc

$2.76
$0.09
(3.37%)
Today
Closed $2.76
$0.01
(0.36%)
After Hours
Reported EarningsAug 7
Mkt Cap$12.21M
Vol49,967.00

About KPRX

Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.
48

Neutral Sentiment

How do you feel about KPRX?

Advertisement|Remove ads.